Early smallpox inoculation and acquired protection | Practitioners in several historical societies; no single individual represents the entire development. | Demonstrated that deliberate exposure practices were used in attempts to induce protection against smallpox. | Provided historical foundations for the idea that prior exposure can alter later susceptibility. | Historical variolation was distinct from modern vaccination and carried substantial risks. | | | |
Vaccination against smallpox | | Provided influential experimental evidence that cowpox exposure could protect against smallpox. | Helped establish vaccination as a method of inducing protective immunity. | Vaccination became a central public-health strategy and contributed to the eventual global eradication of smallpox. | Edward Jenner | 1796 and subsequent publications | |
Attenuated vaccine development | | Developed important vaccine approaches using weakened forms of infectious agents, including work involving chicken cholera, anthrax, and rabies. | Strengthened the experimental basis for vaccine development and the relationship between microbial properties and protective immunity. | Attenuation remains one of several principles used in vaccine design, although modern vaccine platforms are diverse. | Louis Pasteur and collaborators | 19th century | |
Phagocytosis | | Demonstrated that certain cells can engulf foreign particles and microorganisms. | Established a foundational cellular mechanism of innate defence. | Phagocytosis is central to the functions of neutrophils, macrophages, and other phagocytic cells. | Elie Metchnikoff | Late 19th century | |
Antitoxins and serum-mediated protection | | Demonstrated that serum from appropriately immunized animals could contain protective antitoxic activity. | Provided key evidence for transferable humoral protective factors. | Contributed to the foundations of antibody-mediated immunity and passive immunization. | | 1890 | Emil von Behring and Shibasaburo Kitasato |
Complement as a serum defence system | | Research identified heat-sensitive serum activity that could cooperate with antibodies in the destruction of susceptible targets. | Established the importance of soluble innate and antibody-associated effector mechanisms. | The complement system is now understood as a network of plasma proteins involved in inflammation, opsonization, and membrane attack. | | Late 19th and early 20th centuries | Jules Bordet and other early immunologists |
Anaphylaxis | | Investigated severe reactions occurring after repeated exposure to certain substances. | Showed that immune-related responses can sometimes cause harm rather than protection. | Contributed to the development of allergy and hypersensitivity research. | | Early 20th century | Charles Richet and collaborators |
Blood groups and immunological compatibility | | Identified the ABO blood group system through agglutination reactions. | Demonstrated the importance of specific antigen-antibody interactions in biological compatibility. | Blood-group knowledge is essential for safe transfusion practice. | Karl Landsteiner | 1900–1901 | |
Antibody specificity and immune recognition | | Established theoretical and experimental foundations for understanding specific recognition between antibodies and antigens. | Helped explain why antibodies can distinguish particular molecular structures. | Antigen-specific recognition is central to immunodiagnostics, vaccine evaluation, and antibody-based treatment. | | Late 19th and early 20th centuries | Multiple contributors, including Paul Ehrlich and later experimental immunologists |
Clonal selection theory | | Proposed that antigen-specific lymphocyte clones are selected and expanded when they encounter suitable antigens. | Provided a central explanatory framework for adaptive immune specificity and clonal expansion. | The theory underlies modern understanding of B-cell and T-cell selection and expansion. | Frank Macfarlane Burnet, with important later contributions from other scientists | 1950s | |
Antibody structure | | Established important structural features of immunoglobulins through biochemical research. | Explained how antibodies contain regions associated with antigen binding and biological effector functions. | Antibody structure informs monoclonal antibody engineering and therapeutic design. | | 1950s–1960s | Gerald Edelman and Rodney Porter |
Thymus and lymphocyte development | | Research established the thymus as essential for the development of functional T lymphocytes. | Clarified the distinct developmental roles of major lymphocyte populations. | Thymic selection is fundamental to T-cell development and central immune tolerance. | | Mid-20th century | Multiple contributors, including Jacques Miller |
Major histocompatibility complex and tissue compatibility | | Research established genetically determined tissue compatibility factors and their importance in immune recognition. | Helped explain transplant compatibility and antigen presentation. | MHC molecules, called HLA molecules in humans, are central to T-cell recognition and transplantation immunology. | | 20th century | Multiple contributors, including George Snell, Jean Dausset, and Baruj Benacerraf |
Antigen presentation and MHC restriction | | Demonstrated that T-cell recognition of infected cells depends on the relationship between antigen and self-MHC molecules. | Established a central principle of T-cell recognition. | Explains the role of MHC class I in presenting intracellularly derived peptides to CD8-positive T cells and MHC class II in presenting peptides to CD4-positive T cells. | | 1970s | Peter Doherty and Rolf Zinkernagel |
Monoclonal antibody technology | | Developed a method for producing populations of identical antibodies with a single specificity. | Made highly reproducible antibody reagents widely available. | Monoclonal antibodies are used in research, diagnostics, and treatments. | | 1975 | Georges Köhler and César Milstein |
Recombinational basis of antibody diversity | | Demonstrated that antibody genes are assembled through somatic DNA rearrangements. | Explained a major mechanism generating antigen-receptor diversity. | V(D)J recombination is fundamental to B-cell and T-cell receptor diversity. | | 1970s | Susumu Tonegawa and other immunogenetic researchers |
Regulatory T-cell biology | | Established the importance of specialized regulatory T cells in controlling immune responses and maintaining tolerance. | Clarified that immune regulation is an active biological process rather than simply the absence of activation. | Regulatory T cells are important in autoimmunity, transplantation, cancer, and inflammatory disease research. | | Late 20th century onward | Multiple contributors, including Shimon Sakaguchi |
Immune checkpoint regulation | | Research clarified inhibitory pathways that regulate T-cell activity, including CTLA-4 and PD-1. | Demonstrated that immune responses are controlled by molecular checkpoints. | Checkpoint inhibitors have become important forms of cancer immunotherapy in selected clinical settings. | | Late 20th century and early 21st century | Multiple contributors, including James Allison and Tasuku Honjo |